logo

For the Inventor, By the Inventor

Osaka, Japan

Takuya Higo

This inventor holds 1 USPTO granted patent. Top assignee: Mitsubishi Tanabe Pharma Corporation. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takuya Higo. Retrieved from https://idiyas.com/inventor/takuya-higo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:

goldMedal1 out of 263 
 
Mitsubishi Tanabe Pharma Corporation
 patents

Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents
1. 12735705 - COMPOUND, METHOD AND PHARMACEUTICAL COMPOSITION FOR REGULATING EXPRESSION OF ATAXIN 3 (2026-09-15),

Title: Takuya Higo and Pharmaceutical Innovation

Introduction

Takuya Higo is an inventor associated with Osaka, Japan, and Mitsubishi Tanabe Pharma Corporation. His work includes a patent concerning the regulation of ataxin 3 expression.

Latest Patents

Higo is credited with 1 patent: “COMPOUND, METHOD AND PHARMACEUTICAL COMPOSITION FOR REGULATING EXPRESSION OF ATAXIN 3.” The patent describes a compound, method, and pharmaceutical composition intended to regulate ataxin 3 expression.

Career Highlights

Higo’s listed patent connects his inventive work with pharmaceutical research and development at Mitsubishi Tanabe Pharma Corporation.

Collaborations

Shumpei Murata is identified as Higo’s coworker.

Conclusion

Takuya Higo’s recorded patent reflects his contribution to pharmaceutical innovation through research focused on regulating ataxin 3 expression.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…